Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2023-12-04 00:00:00 ET · period of report 2023-11-30 · accession 0001437749-23-033447 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-04 | 2023-11-30 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | P - Purchase | $0.17 | +20.0K | 388.2K | +5% | +$3,400 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-30 | P | A | 20,000 | $0.17 | 388,171 | D | — | — | (F1) Holdings do not include options to purchase 18,750 shares. |